Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
09/09/2009 | CN101525378A Listonella anguillarum subunit vaccine antigenic protein and application thereof |
09/09/2009 | CN101525377A Method for separating and purifying method of polymyxin E methanesulfonic sodium |
09/09/2009 | CN101525360A Hydrates of macrolides organic acid salts, preparation and application thereof |
09/09/2009 | CN101525359A Hydroxypropyl isoquercitrin, hydroxypropyl isoquercitrin derivative and preparation method thereof |
09/09/2009 | CN101525352A Preparation method of Cidofovir and intermediate thereof |
09/09/2009 | CN101525336A Carbapenem compound containing substituted formohydrazide group |
09/09/2009 | CN101525323A Novel styryl chromone type compound and preparation method and use thereof |
09/09/2009 | CN101525316A Quinoline derivatives, preparation method and applications thereof |
09/09/2009 | CN101525289A Method for separating purified ginkgoic acid with anion exchanger |
09/09/2009 | CN101524544A Composite gel film agent |
09/09/2009 | CN101524541A Gel ointment for treating pointed condyloma |
09/09/2009 | CN101524539A New application of rabies human immunoglobulin in preparing medicine for preventing and controlling Japanese encephalitis and combined vaccine for rabies and Japanese encephalitis |
09/09/2009 | CN101524538A Influenza-pandemic influenza bivalent combined vaccine and preparation method thereof |
09/09/2009 | CN101524537A Influenza oral tablet vaccine, influenza oral slow-release vaccine and preparation methods thereof |
09/09/2009 | CN101524536A Japanese encephalitis vaccine prepared by human embryonic lung fibroblasts and preparation method thereof |
09/09/2009 | CN101524535A Capsular polysaccharide solubilisation and combination vaccines |
09/09/2009 | CN101524534A Capsular polysaccharide solubilisation and combination vaccines |
09/09/2009 | CN101524533A Capsular polysaccharide solubilisation and combination vaccines |
09/09/2009 | CN101524532A Single dose of a mycoplasma hyopneumoniae vaccine |
09/09/2009 | CN101524524A Drug for treating severe cold and preparation method thereof |
09/09/2009 | CN101524517A Compound Chinese and western medicine for treating upper respiratory tract infection |
09/09/2009 | CN101524512A Chinese medicine preparation for treating hepatitis and preparation method thereof |
09/09/2009 | CN101524508A Chinese medicinal composition for preventing and treating avian bird flu diseases |
09/09/2009 | CN101524499A Gynecological lotion and preparation method thereof |
09/09/2009 | CN101524468A Medicine for treating AIDS |
09/09/2009 | CN101524462A Garlic volatile oil composition, preparation method of cream preparation thereof and application of cream preparation to treating microbial infection of skin and mucous membrane |
09/09/2009 | CN101524459A Oil-in-water type garlicin-garlic oil sub-microemulsion as well as method for preparing same |
09/09/2009 | CN101524451A Application of carex rigescens for preparing anti-HIV drug |
09/09/2009 | CN101524445A Traditional Chinese medicine composition for treating chicken and duck diseases |
09/09/2009 | CN101524435A Pure natural drug for treating viral hepatitis |
09/09/2009 | CN101524434A Antibacterial cream for treating rhinitis and preparation method thereof |
09/09/2009 | CN101524430A Traditional Chinese fish drug |
09/09/2009 | CN101524429A Gel film agent for treating eczema, ecthyma, and impetigo |
09/09/2009 | CN101524428A Gel paste for treating eczema, ecthyma, and impetigo |
09/09/2009 | CN101524411A High-capacity Kuhuang injection and preparation method thereof |
09/09/2009 | CN101524390A Chinese medicine for treating shingles |
09/09/2009 | CN101524367A Method for preparing discolored iodine tincture and application thereof |
09/09/2009 | CN101524366A Method for preparing compound biological activity sterilizing fluid |
09/09/2009 | CN101524355A Compound preparation of antituberculosis medicaments, and preparation method thereof |
09/09/2009 | CN101524351A Treating infectious diseases by administering an ICE inhibitor |
09/09/2009 | CN101524337A Prolonged release mucosal bioadhesive system |
09/09/2009 | CN101524333A Amoxicillin dispersible tablet and production method thereof |
09/09/2009 | CN101524331A Polysaccharide-liposome and preparation method and purpose thereof |
09/09/2009 | CN101524190A Disease preventing and curing medicinal mouth-muffle and medicinal composite |
09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
09/09/2009 | CN100537546C Novel alkansulfonamides as endothelin antagonists |
09/09/2009 | CN100537519C Intermediate for preparing benzo-oxazine derivative and its preparing method |
09/09/2009 | CN100536919C Interferon antagon and usage of Flt3L antagon |
09/09/2009 | CN100536916C Novel usage of human antalzyme in the process for preparing ophthalmopathy treating medicine |
09/09/2009 | CN100536853C Ss-l-2'-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
09/09/2009 | CN100536852C Application of L-FMAU for preparation of medicament for combination therapies of hepatitis b virus infection |
09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
09/09/2009 | CN100536833C Improved pharmaceutical formulations |
09/08/2009 | US7585947 IL-7 drug substance, composition, preparation and uses |
09/08/2009 | US7585890 One or more purified flavonoids and purified menthol, in a state of purity such that the purified menthol has a direct antiviral effect in vitro on rhinovirus in WISH cells, or potentiates the antiviral effect in vitro of human interferon - alpha -2b (Intron A) on rhinovirus in WISH cells |
09/08/2009 | US7585884 Pleconaril; reduced side effects |
09/08/2009 | US7585870 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines |
09/08/2009 | US7585861 HIV replication inhibitors; for (multi)drug resistant HIV infection |
09/08/2009 | US7585845 Using protease inhibitor |
09/08/2009 | US7585834 Transport moiety comprises a structure; (ZYZ)nZ, (ZY)nZ, (ZYY)nZ or (ZYYY)nZ, wherein each Z is L-arginine or D-arginine, and each Y is independently an amino acid that does not comprise an amidino or guanidino moiety; n=2-10 |
09/08/2009 | US7585658 Staphylococcus aureus antigenic polypeptides and compositions |
09/08/2009 | US7585623 Syndrome X, metabolic syndrome, multiple risk factor syndrome, insulin resistant syndrome, deadly quartet, and visceral fat syndrome, diabetes, obesity, hypercholesterolemia, and hyperlipoproteinemias, hyperlipidemia, arteriosclerosis, hypertonia, circulatory system disease, hyperphagia |
09/08/2009 | US7585522 Oral immunology using plant product containing a non-enteric pathogen antigen |
09/08/2009 | US7585510 Use of the hypo3 gene, or homologue thereof, in the production of an Neisseria strain for the assessment, treatment or prevention of Neisseria infection; treatment of septicaemia and meningitis caused by Neisseria meningitidis |
09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
09/08/2009 | CA2510933C Methods of delivering materials into the skin, and compositions used therein |
09/08/2009 | CA2442210C Aryl oxime-piperazines useful as ccr5 antagonists |
09/08/2009 | CA2440931C Hiv protease inhibitors based on amino acid derivatives |
09/08/2009 | CA2431984C Antibiotic coating for porous bodies and method for its production as well as its use |
09/08/2009 | CA2355466C Multi-component vaccine comprising at least two antigens from haemophilus influenzae |
09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
09/08/2009 | CA2312840C The use of polyols in combating yeast infection and polyol preparations for said use |
09/08/2009 | CA2295090C 2,4,4-trisubstituted-1,3-dioxolane antifungals |
09/08/2009 | CA2294701C Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
09/08/2009 | CA2218701C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
09/08/2009 | CA2141731C Antifungal agents, processes for the preparation thereof, and intermediates |
09/03/2009 | WO2009108778A1 Sulfonic acid and aldehyde condensation polymers for the treatment and prevention of hpv |
09/03/2009 | WO2009108633A2 Sphingosine 1-phosphate antagonism |
09/03/2009 | WO2009107877A1 Pharmaceutical composition |
09/03/2009 | WO2009107652A1 Agent for enhancing corneal epithelial barrier function |
09/03/2009 | WO2009107223A1 Method of producing ceramide |
09/03/2009 | WO2009106967A1 Novel 7-substituted derivatives of 3-carboxy-oxadiazino-quinolones, preparation thereof and use thereof as anti-bacterial agents |
09/03/2009 | WO2009106885A1 Heterocyclic urea derivatives and methods of use thereof-211 |
09/03/2009 | WO2009106773A2 Transgenic non-human mammal for the constant region of the g-class human immunoglobulin heavy chain and applications thereof |
09/03/2009 | WO2009106714A2 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock animals |
09/03/2009 | WO2009106708A2 Azetidine derivatives, their preparation and their application in therapy |
09/03/2009 | WO2009106579A1 Methods for prognosing the status of tumor patients |
09/03/2009 | WO2009106211A1 Beta-lactones as antibacterial agents |
09/03/2009 | WO2009106085A1 Vaccine compositions comprising saccharide antigens |
09/03/2009 | WO2009105874A1 Composition and method for irrigation of a prepared dental root canal |
09/03/2009 | WO2009087474A3 Agonists for antimicrobial peptide systems |
09/03/2009 | WO2009082818A8 Novel c-21-keto lupane derivatives preparation and use thereof |
09/03/2009 | WO2009082363A8 Method and preparations for treating infection-allergic diseases |
09/03/2009 | WO2009076397A9 Antiviral activity of cyclopentene nitro-ester and derivatives |
09/03/2009 | WO2009070045A3 Imidazole derivatives, process for their preparation, and thier pharmaceutical use |
09/03/2009 | WO2009063492A9 Novel agents for treatment of ailments and dysfunctions |
09/03/2009 | WO2009049742A3 Use of melanotrophin-potentiating factor as a therapeutic agent |
09/03/2009 | WO2009047005A3 A homeopathic complex |
09/03/2009 | WO2009046829A3 Casoxin d as a therapeutic agent |
09/03/2009 | WO2009043480A3 Use of leptin (22-56 ) as a therapeutic agent |